Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL289798 | 0.79 | — | — | |
| SCHEMBL27555150 | 0.79 | — | — | |
| 2-Oxoisohexanoate SCHEMBL6845538 | 0.76 | CA2 (0.50) | OR51E2CA2TDP1ALDH1A1MAPK1 | |
| SCHEMBL401783 | 0.74 | — | — | |
| 2-Oxoisohexanoate SCHEMBL43491 | 0.73 | — | — | |
| 2-Oxoisohexanoate SCHEMBL18302256 | 0.73 | CA2 (0.52) | OR51E2CA2TDP1ALDH1A1MAPK1 | |
| SCHEMBL16114175 | 0.73 | OR51E2 (0.40) | OR51E2CA2TDP1ALDH1A1MAPK1 | |
| SCHEMBL2701354 | 0.72 | — | — | |
| SCHEMBL11919740 | 0.72 | GRIK1 (0.37) | OR51E2TDP1ALDH1A1MAPK1SLC13A3 | |
| SCHEMBL2964153 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009018368-A1 | COMBINATION TREATMENT OF NMDA (N-METHYL-D-ASPARTATE)-ENHANCER, GLYCINE TRANSPORTER INHIBITOR, D-AMINO ACID OXIDASE INHIBITOR (DAAOI) FOR NEUROPSYCHIATRIC DISORDERS | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2009-02-05 | — | — | WO | claimed |
| JP-2002542797-A | — | — | 2002-12-17 | — | — | JP | claimed |
| US-6403144-B1 | LECITHIN ANTISTICK AGENT, NUCLEOTIDE FLAVOR ENHANCER, POLYDIMETHYLSILOXANE ANTIFOAM AGENT, RELATIVELY LOW AMOUNTS YET PROVIDE IMPROVED FLAVOR, TEXTURE AND AROMA OF COOKING OIL, COOKING SPRAY, AND SHORTENING | THE PROCTER & GAMBLE CO. | 2002-06-11 | — | — | US | claimed |
| US-20020045001-A1 | Food preparation compositions | THE J.M. SMUCKER COMPANY | 2002-04-18 | — | — | US | claimed |
| EP-1176879-A1 | FOOD PREPARATION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2002-02-06 | — | — | EP | claimed |
| WO-2000065933-A1 | FOOD PREPARATION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-09 | — | — | WO | claimed |
| US-11529342-B2 | Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2022-12-20 | — | — | US | disclosed |
| EP-3006023-B1 | SORBIC ACID AND DERIVATIVES THEREOF TO ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL | LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT (US) | 2019-06-26 | — | — | EP | disclosed |
| US-20190151301-A1 | SORBIC AND BENZOIC ACID AND DERIVATIVES THEREOF ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2019-05-23 | — | — | US | disclosed |
| EP-3006024-B1 | BENZOIC ACID OR SALTS THEREOF TO ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL | LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT (US) | 2019-03-20 | — | — | EP | disclosed |
| US-10149845-B2 | Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2018-12-11 | — | — | US | disclosed |
| US-10039730-B2 | Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2018-08-07 | — | — | US | disclosed |
| US-20170189358-A1 | SORBIC AND BENZOIC ACID AND DERIVATIVES THEREOF ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2017-07-06 | — | — | US | disclosed |
| WO-2002066672-A2 | TREATMENT OF CNS DISORDERS USING D-AMINO ACID OXIDASE AND D-ASPARTATE OXIDASE ANTAGONISTS | GENSET S.A. (FR) | 2002-08-29 | — | — | WO | disclosed |
| US-6403144-B1 | LECITHIN ANTISTICK AGENT, NUCLEOTIDE FLAVOR ENHANCER, POLYDIMETHYLSILOXANE ANTIFOAM AGENT, RELATIVELY LOW AMOUNTS YET PROVIDE IMPROVED FLAVOR, TEXTURE AND AROMA OF COOKING OIL, COOKING SPRAY, AND SHORTENING | THE PROCTER & GAMBLE CO. | 2002-06-11 | — | — | US | disclosed |
| US-20020045001-A1 | Food preparation compositions | THE J.M. SMUCKER COMPANY | 2002-04-18 | — | — | US | disclosed |
| EP-1176873-A1 | FLAVOR ENHANCING OILS | THE PROCTER & GAMBLE COMPANY (US) | 2002-02-06 | — | — | EP | disclosed |
| EP-1176879-A1 | FOOD PREPARATION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2002-02-06 | — | — | EP | disclosed |
| WO-2000065933-A1 | FOOD PREPARATION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000065926-A1 | FLAVOR ENHANCING OILS | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-09 | — | — | WO | disclosed |